drugset / Trial / NCT00887718

Positron Emission Tomography(PET) in Lymphoma Assessment

NCT00887718

Completed 103 enrolled University Health Network, Toronto
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

This study examines the role of a diagnostic test called Positron Emission Tomography (PET) scanning in patients with malignant lymphoma. The primary goal of this study is to find out how well PET scanning can detect malignant (cancerous) lymphoma, and how often this extra information will result in a change of stage of disease, or will result in a change in treatment management plans of patients with lymphoma.

Timeline

Start
2007-08
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Background 18F-FDG Diagnostic / imaging agent